2Lau DT-Y,Khokhar MF,Doo E,et al.Long-term therapy of chronichepatitis B with lamivudine[J].Hepatology,2000,32:828834.
3Goldstein A L,Low TL,Mc Adoom,et al.Thymosin alpha1:isolation and sequence analysis of an immunologically active thymic polypeptide[J]. Natl A Cad Sci, 1977,74:725-729.
4Naylor PH, Friedman-Kien A, Hersh E,et al. Thymosin alpha1 and thymosin beta 4 in serum: comparison of normal,cord,homosexual and AIDS serum[J]. Int J Immunopharmacol, 1986, 8(7) :667-676.
5Knutsen AP, Freeman J J, Mueller KR, et al. Thymosin-alpha1 stimulates maturation of CD34^+ stem ceils into CD3^+、CD4^+ cells in an in vitro thymic epithelia organ coculture model [J]. Int J Immunopharmacol, 1999,21:15.
6Baumann CA,Badamchian M,Goldsteln AL.Tα1 antagonizes induced apoptosis of developing thymocytes in vitro[J]. Mol Cell Biol, 1995,6S:356.
7Baumann CA, Badamchian M, Goldstein AL.Thymosin alpha( 1 )is a time and dose-dependent antagonist of dexamethasone-induced apeptosis of routine thymocytes in vitro [J]. Int J Immunopharmacol,2000,22:1057- 1066.
8Roy R,Singh SM, Shanker A. Mechanism of thymocyte apoptosis induced by serum of tumor-bearing host: the molecular events involved and their inhibition by thymosin alphal-1[J]. Int J Immunopharmacol,2000,22: 309-321.
9Beuth J, Schierholz JM, Mayer G. Thymosin alpha (1)application augments ummune response and down-regulates tumor weight and organ colonization in BALB/c-mice[J]. Cancer Lett, 2000,159: 9-13.
10Silecchia G,Guamo E,Sinlbaldi-Vallebona P,et al. Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha1 and interleukin -2 after intraperitoneal 5-fluorouracil delivery [J]. Cancer Immunol Immunother, 1999,48:172-178.
